These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 19712256)
41. Fluorofenidone attenuates diabetic nephropathy and kidney fibrosis in db/db mice. Wang LH; Liu JS; Ning WB; Yuan QJ; Zhang FF; Peng ZZ; Lu MM; Luo RN; Fu X; Hu GY; Wang ZH; Tao LJ Pharmacology; 2011; 88(1-2):88-99. PubMed ID: 21847000 [TBL] [Abstract][Full Text] [Related]
42. [Urine protein from patients with lupus nephritis stimulates transdifferentiation and high expression of collagen in renal tubular cells]. Liu GX; Deng AG; Yu XQ; Duan WJ; Wen Q; Luo N; Li XY Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3429-32. PubMed ID: 18476545 [TBL] [Abstract][Full Text] [Related]
43. All-trans retinoic acid inhibits the increases in fibronectin and PAI-1 induced by TGF-beta1 and Ang II in rat mesangial cells. Liu X; Lü L; Tao BB; Zhu YC Acta Pharmacol Sin; 2008 Sep; 29(9):1035-41. PubMed ID: 18718172 [TBL] [Abstract][Full Text] [Related]
44. Secretion of collagen type IV by human renal fibroblasts is increased by high glucose via a TGF-beta-independent pathway. Lam S; van der Geest RN; Verhagen NA; Daha MR; van Kooten C Nephrol Dial Transplant; 2004 Jul; 19(7):1694-701. PubMed ID: 15150349 [TBL] [Abstract][Full Text] [Related]
45. NADPH oxidase mediates interleukin-6 expression in cerulein-stimulated pancreatic acinar cells. Yu JH; Lim JW; Kim H; Kim KH Int J Biochem Cell Biol; 2005 Jul; 37(7):1458-69. PubMed ID: 15833277 [TBL] [Abstract][Full Text] [Related]
46. Effects of pirfenidone on proliferation, migration, and collagen contraction of human Tenon's fibroblasts in vitro. Lin X; Yu M; Wu K; Yuan H; Zhong H Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3763-70. PubMed ID: 19264889 [TBL] [Abstract][Full Text] [Related]
47. Fluorofenidone attenuates TGF-β1-induced lung fibroblast activation via restoring the expression of caveolin-1. Liu J; Song C; Xiao Q; Hu G; Tao L; Meng J Shock; 2015 Feb; 43(2):201-7. PubMed ID: 25394239 [TBL] [Abstract][Full Text] [Related]
48. Fluorofenidone inhibits Ang II-induced apoptosis of renal tubular cells through blockage of the Fas/FasL pathway. Ning WB; Hu GY; Peng ZZ; Wang L; Wang W; Chen JY; Zheng X; Li J; Tao LJ Int Immunopharmacol; 2011 Sep; 11(9):1327-32. PubMed ID: 21586345 [TBL] [Abstract][Full Text] [Related]
49. Leptospiral outer membrane protein induces extracellular matrix accumulation through a TGF-beta1/Smad-dependent pathway. Tian YC; Chen YC; Hung CC; Chang CT; Wu MS; Phillips AO; Yang CW J Am Soc Nephrol; 2006 Oct; 17(10):2792-8. PubMed ID: 16928805 [TBL] [Abstract][Full Text] [Related]
50. [Effects of C-reactive protein on the expression of transforming growth factor β1 and receptors on human renal tubular epithelial cells]. Xie KQ; Shi W; Li DF; Zhang B; Liu SX; Zhou HW Zhonghua Yi Xue Za Zhi; 2012 May; 92(18):1281-4. PubMed ID: 22883070 [TBL] [Abstract][Full Text] [Related]
51. Intermedin inhibits unilateral ureteral obstruction-induced oxidative stress via NADPH oxidase Nox4 and cAMP-dependent mechanisms. Qiao X; Wang L; Wang Y; Su X; Qi Y; Fan Y; Peng Z Ren Fail; 2017 Nov; 39(1):652-659. PubMed ID: 28805491 [TBL] [Abstract][Full Text] [Related]
52. Fluorofenidone attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice via restoring caveolin 1 expression and inhibiting mitogen-activated protein kinase signaling pathway. Meng J; Zou Y; Hu C; Zhu Y; Peng Z; Hu G; Wang Z; Tao L Shock; 2012 Nov; 38(5):567-73. PubMed ID: 23042199 [TBL] [Abstract][Full Text] [Related]
53. NADPH oxidase-2 is a key regulator of human dermal fibroblasts: a potential therapeutic strategy for the treatment of skin fibrosis. Zhang GY; Wu LC; Dai T; Chen SY; Wang AY; Lin K; Lin DM; Yang JQ; Cheng B; Zhang L; Gao WY; Li ZJ Exp Dermatol; 2014 Sep; 23(9):639-44. PubMed ID: 24981855 [TBL] [Abstract][Full Text] [Related]
54. Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts. Gao X; He X; Luo B; Peng L; Lin J; Zuo Z Eur J Pharmacol; 2009 Mar; 606(1-3):115-20. PubMed ID: 19374881 [TBL] [Abstract][Full Text] [Related]
55. Effect of angiotensin II and angiotensin II type 1 receptor antagonist on the proliferation, contraction and collagen synthesis in rat hepatic stellate cells. Liu J; Gong H; Zhang ZT; Wang Y Chin Med J (Engl); 2008 Jan; 121(2):161-5. PubMed ID: 18272044 [TBL] [Abstract][Full Text] [Related]
56. Fluorofenidone attenuates bleomycin-induced pulmonary fibrosis by inhibiting eukaryotic translation initiation factor 3a (eIF3a) in rats. Wu YH; Li XW; Li WQ; Li XH; Li YJ; Hu GY; Liu ZQ; Li D Eur J Pharmacol; 2016 Feb; 773():42-50. PubMed ID: 26821114 [TBL] [Abstract][Full Text] [Related]
57. The regulation of NADPH oxidase and its association with cell proliferation in human lens epithelial cells. Wang Y; Lou MF Invest Ophthalmol Vis Sci; 2009 May; 50(5):2291-300. PubMed ID: 19136702 [TBL] [Abstract][Full Text] [Related]
58. [NADPH oxidase-derived reactive oxygen species involved in angiotensin II-induced monocyte chemoattractant protein-1 expression in mesangial cells]. Chen Y; Zhang AH; Huang SM; Ding GX; Zhang WZ; Bao HY; Wu HM; Chen RH Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):456-61. PubMed ID: 19781192 [TBL] [Abstract][Full Text] [Related]
59. Fluorofenidone attenuates oxidative stress and renal fibrosis in obstructive nephropathy via blocking NOX2 (gp91phox) expression and inhibiting ERK/MAPK signaling pathway. Qin J; Mei WJ; Xie YY; Huang L; Yuan QJ; Hu GY; Tao LJ; Peng ZZ Kidney Blood Press Res; 2015; 40(1):89-99. PubMed ID: 26029782 [TBL] [Abstract][Full Text] [Related]